| | 55552 | | 29.11.2000 | | GlaxoSmithKline AG | | 26.10.2005 | | | | | | | | | | 03.04.30. | | | | 03.04.30. | | IP |
| Seq.-No. | Product | Description | Galenic form | ATC-classification | |
---|
01 | Seretide 50 | Dosier-Aerosol | Metered dose aerosol (Salmeterol 25 µg, Fluticasoni Propionas 50 µg) | R03AK06 | CI | 02 | Seretide 125 | Dosier-Aerosol | Metered dose aerosol (Salmeterol 25 µg, Fluticasoni Propionas 125 µg) | R03AK06 | CI | 03 | Seretide 250 | Dosier-Aerosol | Metered dose aerosol (Salmeterol 25 µg, Fluticasoni Propionas 250 µg) | R03AK06 | CI |
|
|